Evaluation of Splenic Irradiation in Chronic Lymphatic Leukemia

Maastricht Radiation Oncology

Status: Withdrawn

Conditions: Leukemia, Chronic Lymphatic

Treatments: Radiation: splenic irradiation

Study type: Observational

Funder types: Other

Identifiers

NCT02020109

13-11-05/06-extern-6295

Details and patient eligibility

About

Retrospective evaluation on the effect of splenic irradiation on clinical and hematological response and toxicity in patients with chronic lymphatic leukaemia (CLL).

Full description

The study will include patients with CLL treated with splenic irradiation in Maastro Clinic, Maastricht, The Netherlands, Maxima Medisch Centrum Veldhoven/Catharina hospital, Eindhoven, The Netherlands and Modena hospital, Modena, Italy. Data will be collected from patient records in an uniform database. Data will include demographic data, CLL stadium (RAI and Binet) at diagnosis and at the time of irradiation treatment, clinical data at diagnosis (haematology), splenic irradiation data, follow-up data such as date of progression or death

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with chronic lymphatic leukaemia.

Exclusion criteria

• none

Trial design

0 participants in 1 patient group

Patients with Chronic Lymphatic Leukemia

Description:

Patients with Chronic Lymphatic Leukemia treated with splenic irradiation

Treatment:

Radiation: splenic irradiation